☰

Rahasson R. Ager, Ph.D. - Publications

Affiliations: 
2009 Biological Sciences - Ph.D. University of California, Irvine, Irvine, CA 
Area:
Molecular Biology, Neuroscience Biology
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Baglietto-Vargas D, Forner S, Cai L, Martini AC, Trujillo-Estrada L, Swarup V, Nguyen MMT, Do Huynh K, Javonillo DI, Tran KM, Phan J, Jiang S, Kramár EA, Nuñez-Diaz C, Balderrama-Gutierrez G, ... ... Ager RR, et al. Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology. Nature Communications. 12: 2421. PMID 33893290 DOI: 10.1038/s41467-021-22624-z  0.608
2019 Forner S, Martini AC, Prieto GA, Dang CT, Rodriguez-Ortiz CJ, Reyes-Ruiz JM, Trujillo-Estrada L, da Cunha C, Andrews EJ, Phan J, Vu Ha J, Chang AVZD, Levites Y, Cruz PE, Ager R, et al. Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus. Scientific Reports. 9: 15936. PMID 31685865 DOI: 10.1038/S41598-019-52324-0  0.483
2019 Cadete Martini A, Gomez-Arboledas A, Forner S, Rodriguez-Ortiz CJ, McQuade A, Danhash E, Phan J, Javonillo D, Ha JV, Tram M, Trujillo-Estrada L, da Cunha C, Ager RR, Davila JC, Kitazawa M, et al. Amyloid-beta impairs TOM1-mediated IL-1R1 signaling. Proceedings of the National Academy of Sciences of the United States of America. PMID 31570577 DOI: 10.1073/Pnas.1914088116  0.443
2019 Trujillo-Estrada L, Nguyen C, da Cunha C, Cai L, Forner S, Martini AC, Ager RR, Prieto GA, Cotman CW, Baglietto-Vargas D, LaFerla FM. Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models. Aging Cell. e12919. PMID 30809950 DOI: 10.1111/Acel.12919  0.365
2018 Baglietto-Vargas D, Prieto GA, Limon A, Forner S, Rodriguez-Ortiz CJ, Ikemura K, Ager RR, Medeiros R, Trujillo-Estrada L, Martini AC, Kitazawa M, Davila JC, Cotman CW, Gutierrez A, LaFerla FM. Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease. Aging Cell. e12791. PMID 29877034 DOI: 10.1111/Acel.12791  0.48
2016 Baglietto-Vargas D, Shi J, Yaeger DM, Ager R, LaFerla FM. Diabetes and Alzheimer's Disease Crosstalk. Neuroscience and Biobehavioral Reviews. PMID 26969101 DOI: 10.1016/J.Neubiorev.2016.03.005  0.431
2015 Yeung ST, Martinez-Coria H, Ager RR, Rodriguez-Ortiz CJ, Baglietto-Vargas D, LaFerla FM. Repeated cognitive stimulation alleviates memory impairments in an Alzheimer's disease mouse model. Brain Research Bulletin. 117: 10-5. PMID 26162480 DOI: 10.1016/J.Brainresbull.2015.07.001  0.408
2015 Baglietto-Vargas D, Chen Y, Suh D, Ager RR, Rodriguez-Ortiz CJ, Medeiros R, Myczek K, Green KN, Baram TZ, LaFerla FM. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice. Journal of Neurochemistry. PMID 26077803 DOI: 10.1111/Jnc.13195  0.453
2015 Ager RR, Davis JL, Agazaryan A, Benavente F, Poon WW, LaFerla FM, Blurton-Jones M. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss. Hippocampus. 25: 813-26. PMID 25530343 DOI: 10.1002/Hipo.22405  0.489
2015 Dunn HC, Ager RR, Baglietto-Vargas D, Cheng D, Kitazawa M, Cribbs DH, Medeiros R. Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model. Journal of Alzheimer's Disease : Jad. 43: 893-903. PMID 25125468 DOI: 10.3233/Jad-141335  0.519
2015 Martinez-Coria H, Yeung ST, Ager RR, Rodriguez-Ortiz CJ, Baglietto-Vargas D, LaFerla FM. Corrigendum to "Repeated cognitive stimulation alleviates memory impairments in an Alzheimer's disease mouse model" [Brain Res. Bull. 117 (2015) 10-15] DOI 10.1016/j.brainresbull.2015.07.001 Brain Research Bulletin. 119: 104. DOI: 10.1016/J.Brainresbull.2015.08.005  0.358
2015 Yeung ST, Martinez-Coria H, Ager RR, Rodriguez-Ortiz CJ, Baglietto-Vargas D, LaFerla FM. Repeated cognitive stimulation alleviates memory impairments in an Alzheimer's disease mouse model Brain Research Bulletin. 117: 10-15. DOI: 10.1016/j.brainresbull.2015.07.001  0.31
2015 Ager RR, LaFerla FM. Stem Cell Therapy for Alzheimer's Disease Reviews in Cell Biology and Molecular Medicine. 1: 1-27. DOI: 10.1002/3527600906.Mcb.201500009  0.484
2014 Walls KC, Ager RR, Vasilevko V, Cheng D, Medeiros R, LaFerla FM. p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice. Neuroscience Letters. 575: 96-100. PMID 24887583 DOI: 10.1016/J.Neulet.2014.05.047  0.493
2012 Blurton-Jones M, Ager R, Nerhus J, Agazaryan A, Huhn S, Capela A, LaFerla F. P3-345: Restoration of memory in mouse models of Alzheimer's disease and neuronal loss: A new paradigm using human neural stem cell therapy Alzheimer's & Dementia. 8: P577-P578. DOI: 10.1016/J.Jalz.2012.05.1569  0.384
2012 Ager R, Blurton-Jones M, Davis J, Agazaryan A, LaFerla F. P2-391: Human neural stem cell transplantation results in memory improvement in a 3xTg Alzheimer's disease model mice Alzheimer's & Dementia. 8: P399-P400. DOI: 10.1016/J.Jalz.2012.05.1101  0.388
2010 Ager RR, Fonseca MI, Chu SH, Sanderson SD, Taylor SM, Woodruff TM, Tenner AJ. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease. Journal of Neurochemistry. 113: 389-401. PMID 20132482 DOI: 10.1111/J.1471-4159.2010.06595.X  0.654
2010 Woodruff TM, Ager RR, Tenner AJ, Noakes PG, Taylor SM. The role of the complement system and the activation fragment C5a in the central nervous system. Neuromolecular Medicine. 12: 179-92. PMID 19763906 DOI: 10.1007/S12017-009-8085-Y  0.577
2009 Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, LaFerla FM, Taylor SM, Woodruff TM, Tenner AJ. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. Journal of Immunology (Baltimore, Md. : 1950). 183: 1375-83. PMID 19561098 DOI: 10.4049/Jimmunol.0901005  0.681
2009 Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Köhl J. The role of the anaphylatoxins in health and disease. Molecular Immunology. 46: 2753-66. PMID 19477527 DOI: 10.1016/J.Molimm.2009.04.027  0.56
2008 Li M, Ager RR, Fraser DA, Tjokro NO, Tenner AJ. Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation. Molecular Immunology. 45: 3244-52. PMID 18400300 DOI: 10.1016/J.Molimm.2008.02.022  0.573
2008 Ager R, Fonseca M, Chu S, Yazan O, Woodruff T, Sanderson S, Taylor S, Tenner A. Decreases in Alzheimer's disease like pathology associated with C5aR inhibition correlate with improved performance in a passive avoidance task Molecular Immunology. 45: 4109. DOI: 10.1016/J.Molimm.2008.08.042  0.579
2008 Fonseca MI, Ager RR, Woodruff TM, Chu S, Yazan O, Sanderson S, LaFerla FM, Taylor SM, Tenner AJ. O4-02-08: Chronic treatment with C5a antagonist decreases pathology in two mouse models of Alzheimer's disease Alzheimer's & Dementia. 4: T188-T188. DOI: 10.1016/J.Jalz.2008.05.516  0.602
Show low-probability matches.